We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » BioTelemetry, CardioNet Settle False Claims Act Allegations for $44.8 Million
BioTelemetry, CardioNet Settle False Claims Act Allegations for $44.8 Million
BioTelemetry and its subsidiary CardioNet — both owned by Philips — have reached a $44.8 million agreement with the Department of Justice (DOJ) to resolve False Claims Act allegations that the companies billed the federal government for test analysis performed outside the U.S.